Contact
Please use this form to send email to PR contact of this press release:
Basilea achieves preclinical milestone in oncology collaboration on potential first-in-class kinase inhibitor
TO:
Please use this form to send email to PR contact of this press release:
Basilea achieves preclinical milestone in oncology collaboration on potential first-in-class kinase inhibitor
TO: